Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients

J Am Acad Dermatol. 2018 Mar;78(3):599-601.e1. doi: 10.1016/j.jaad.2017.09.037. Epub 2017 Sep 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Age Factors
  • Alopecia Areata / drug therapy*
  • Cyclopropanes / adverse effects
  • Cyclopropanes / therapeutic use*
  • Humans
  • Immunotherapy / methods
  • Middle Aged
  • Photosensitizing Agents / adverse effects
  • Photosensitizing Agents / therapeutic use*
  • Retrospective Studies
  • Self Care*
  • Young Adult

Substances

  • Cyclopropanes
  • Photosensitizing Agents
  • diphenylcyclopropenone